Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Jade Biosciences, Inc. (JBIO) had Return on Equity of -12.68% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-55.77M |
|
-- |
|
-- |
|
$58.92M |
|
$-58.92M |
|
$3.17M |
|
$-55.75M |
|
$-55.75M |
|
$-55.77M |
|
$-55.77M |
|
$-55.77M |
|
$-55.77M |
|
$-58.92M |
|
$-59.27M |
|
61.05M |
|
61.05M |
|
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$471.25M |
|
$0.14M |
|
$0.86M |
|
$472.11M |
|
$31.57M |
|
-- |
|
$0.63M |
|
$32.20M |
|
$439.91M |
|
$439.92M |
|
$439.92M |
|
63.56M |
|
| Cash Flow Statement Financials | |
$-67.74M |
|
$-106.10M |
|
$192.73M |
|
$88.44M |
|
$107.25M |
|
$18.81M |
|
$21.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-67.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-12.68% |
-12.68% |
|
-11.81% |
|
-12.68% |
|
$6.92 |
|
$-1.11 |
|
$-1.11 |
|